Correction: Fetal Toxic Effects of Angiotensin II Receptor Antagonists: Case Report and Follow-Up after Birth

2005 ◽  
Vol 39 (2) ◽  
pp. 389-389
Keyword(s):  
Case Report ◽  
Angiotensin Ii ◽  
Toxic Effects ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Receptor Antagonists

Fetal Toxic Effects of Angiotensin II Receptor Antagonists: Case Report and Follow-Up after Birth

2005 ◽  
Vol 39 (1) ◽  
pp. 157-161 ◽  
Author(s):  
Marie-Andrée Bos-Thompson ◽  
Dominique Hillaire-Buys ◽  
Françoise Muller ◽  
Hervé Dechaud ◽  
Evelyne Mazurier ◽  
...  
Keyword(s):  
Case Report ◽  
Angiotensin Ii ◽  
Toxic Effects ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Receptor Antagonists

scholarly journals Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure

2018 ◽  
Vol 2018 ◽  
pp. 1-3
Author(s):  
K. Wegleiter ◽  
M. Waltner-Romen ◽  
R. Trawoeger ◽  
U. Kiechl-Kohlendorfer ◽  
E. Griesmaier
Keyword(s):  
Angiotensin Ii ◽  
Receptor Antagonist ◽  
Neonatal Period ◽  
Clinical Symptoms ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Angiotensin Ii Receptor Antagonist ◽  
Receptor Antagonists

Fetal angiotensin II receptor antagonist exposure is associated with major complications and even death when administered during pregnancy. Neonates frequently require intensive care treatment, and mortality is high. Despite this well-known risk potential, a considerable number of women still receive angiotensin II receptor antagonists during pregnancy to treat arterial hypertension. Although clinical symptoms in the neonatal period are well described, few reports address long-term follow-up after fetal exposure to angiotensin II receptor antagonists. We here report on a patient who was unwittingly exposed to olmesartan medoxomil during pregnancy. After birth, the neonate presented with mild clinical symptoms, mainly affecting the kidneys. However, neurodevelopmental follow-up revealed a delay in motor development with muscular hypotonia and failure to thrive at age 2 years. This case highlights the fact that, despite not causing neurological symptoms in the neonatal period, fetal angiotensin II receptor antagonist exposure during pregnancy might lead to neurodevelopmental impairment in later life.

Fetal toxic effects and angiotensin-II-receptor antagonists

The Lancet ◽  
2001 ◽  
Vol 358 (9277) ◽  
pp. 241-242 ◽  
Author(s):  
Jelena Martinovic ◽  
Alexandra Benachi ◽  
Nicole Laurent ◽  
Farida Daïkha-Dahmane ◽  
Marie Claire Gubler
Keyword(s):  
Angiotensin Ii ◽  
Toxic Effects ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Receptor Antagonists

Investigation Planning and Bioequivalence evaluation of Angiotensin II Receptor Antagonists

2019 ◽  
Vol 53 (8) ◽  
pp. 680-684
Author(s):  
D. P. Romodanovskii ◽  
D. V. Goryachev ◽  
A. L. Khokhlov ◽  
A. N. Miroshnikov
Keyword(s):  
Angiotensin Ii ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Receptor Antagonists

ChemInform Abstract: Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy

ChemInform ◽  
2010 ◽  
Vol 27 (21) ◽  
pp. no-no
Author(s):  
R. R. WEXLER ◽  
W. J. GREENLEE ◽  
J. D. IRVIN ◽  
M. R. GOLDBERG ◽  
K. PRENDERGAST ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Antihypertensive Therapy ◽  
Next Generation ◽  
Angiotensin Ii Receptor ◽  
Angiotensin Ii Receptor Antagonists ◽  
Receptor Antagonists
Sign in / Sign up

Export Citation Format

Share Document